Constarium
← Search

Omics · study · 2026

Super-enhancer-driven MAFK promotes glioblastoma growth by transcriptionally activating immune-related genes and is stabilized by the deubiquitinase USP36

Listed in NCBI GEO

Glioblastoma (GBM) is the most aggressive primary malignant tumor of the adult central nervous system, with a median survival of less than 15 months despite surgery combined with radiochemotherapy.

Description

Super-enhancers (SEs) are large clusters of cis-regulatory elements densely marked by H3K27ac that drive high-level expression of key oncogenes. In this study, we systematically identified SE-regulated genes in GBM by integrating H3K27ac ChIP-seq data from five glioma cell lines and applying the ROSE algorithm.

We report for the first time that MAFK, a small Maf family transcription factor, is controlled by an SE in GBM. Three-dimensional genome profiling revealed prominent long-range chromatin interactions between the MAFK-SE and the MAFK locus, and E2 was delineated as the principal active enhancer element. Functionally, MAFK depletion markedly impaired GBM cell proliferation, induced G2/M arrest and apoptosis in vitro, and suppressed subcutaneous xenograft growth in vivo.

Read the rest (2 more)

Integrative RNA-seq and CUT&Tag analyses showed that MAFK directly binds and transcriptionally activates immune-related genes, including IL6, IRF1, STAT1, NFKB1 and JAK2, implicating it in the regulation of GBM cell immune responses. Moreover, co-immunoprecipitation coupled with mass spectrometry identified the deubiquitinase USP36 as a novel MAFK-interacting protein. USP36 selectively removed K48-linked polyubiquitin chains from MAFK, thereby protecting it from proteasomal degradation and sustaining its steady-state level.

Collectively, these data uncover a SE–MAFK–USP36 regulatory axis that drives GBM progression and nominate MAFK as a potential therapeutic target.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65% · Mass spectrometry 75% · RNA sequencing 65%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34836610 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:genome-binding-occupancy-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:mass-spectrometryenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title